Zhitong Finance and Economics learned that a report cited by Morgan Stanley showed that after adjusting monthly grocery spending based on factors such as household size and income, households that purchased GLP-1** drugs spent 6-9% less on groceries than those who did not buy the drug, with a particularly large decline in grocery spending.
Households that buy** medicines are spending significantly less on snacks, pastries and ice cream, while spending on healthy foods such as yogurt, fish and vegetables is seeing an increase, the report adds.
One for 9The latest Numerator survey of 20,000 people shows that 123% of households said they had members taking GLP-1** drugs, such as Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound.
"The products most affected by GLP-1** include snacks, pastries and ice cream, while yogurt, fish and vegetable snacks are the most affected," said Da Mo analyst Pamela Kaufman and her team. "Our previous investigative work has shown a significant reduction in consumption in the unhealthy category when GLP-1 drugs are taken. ”
Households spent more on groceries than on non-GLP-1 HHS, but they spent less after starting the medication. Prior to starting**, GLP-1 HHS spent an average of more than $150 per month on groceries compared to non-GLP-1 HHSs," Kaufman said. "Part of the reason for this difference is larger family sizes, higher incomes, more children, and generally higher food spending. ”
When monthly grocery spending was indexed to adjust for the above differences, GLP-1 households experienced a 6% to 9% decrease in monthly grocery spending compared to non-GLP-1 households. ”